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Abstract
Background: Data on the burden of the 2009 influenza pandemic in Asia are limited. Influenza A(H1N1)pdm09 was first
reported in Thailand in May 2009. We assessed incidence and epidemiology of influenza-associated hospitalizations during
2009–2010.
Methods: We conducted active, population-based surveillance for hospitalized cases of acute lower respiratory infection
(ALRI) in all 20 hospitals in two rural provinces. ALRI patients were sampled 1:2 for participation in an etiology study in
which nasopharyngeal swabs were collected for influenza virus testing by PCR.
Results: Of 7,207 patients tested, 902 (12.5%) were influenza-positive, including 190 (7.8%) of 2,436 children aged ,5 years;
86% were influenza A virus (46% A(H1N1)pdm09, 30% H3N2, 6.5% H1N1, 3.5% not subtyped) and 13% were influenza B
virus. Cases of influenza A(H1N1)pdm09 first peaked in August 2009 when 17% of tested patients were positive. Subsequent
peaks during 2009 and 2010 represented a mix of influenza A(H1N1)pdm09, H3N2, and influenza B viruses. The estimated
annual incidence of hospitalized influenza cases was 136 per 100,000, highest in ages ,5 years (477 per 100,000) and .75
years (407 per 100,000). The incidence of influenza A(H1N1)pdm09 was 62 per 100,000 (214 per 100,000 in children ,5
years). Eleven influenza-infected patients required mechanical ventilation, and four patients died, all adults with influenza
A(H1N1)pdm09 (1) or H3N2 (3).
Conclusions: Influenza-associated hospitalization rates in Thailand during 2009–10 were substantial and exceeded rates
described in western countries. Influenza A(H1N1)pdm09 predominated, but H3N2 also caused notable morbidity.
Expanded influenza vaccination coverage could have considerable public health impact, especially in young children.
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Introduction
Increasing evidence supports influenza viruses as an important
cause of disease in tropical and subtropical regions, particularly in
young children and older adults [1,2,3,4,5]. Most studies from
tropical Asia have documented year-round influenza virus
circulation with fairly consistent seasonal peaks. However, the
contribution of influenza viruses to severe disease in this setting,
including pneumonia and especially among children, continues to
be underappreciated. While influenza vaccination is universally
recommended to all persons 6 months of age and older in the
United States [6], vaccination guidelines are either non-existent or
far more limited in most tropical countries, where the burden may
be as great or greater.
The first cases of influenza A(H1N1)pdm09 infection were
detected in the United States in April 2009. The ensuing
pandemic resulted in heightened influenza surveillance worldwide.
However, few surveillance systems included established catchment
populations, meaning that population-based estimates of influenza
A(H1N1)pdm09 incidence are limited, especially in tropical and
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resource limited settings. Robust incidence data are needed to
estimate the burden of the 2009 pandemic and are important to
inform policy discussions about prevention and control strategies
for influenza in general.
The first cases of influenza A(H1N1)pdm09 were reported in
Thailand in May 2009. Although influenza A(H1N1)pdm09
quickly became the predominant circulating influenza subtype,
circulation of seasonal influenza viruses continued. We used
ongoing active, population-based surveillance in two Thailand
provinces [7] to describe the incidence and epidemiology of
hospitalizations associated with influenza A(H1N1)pdm09 and
influenza viruses overall, and to compare characteristics among
patients infected with influenza A(H1N1)pdm09 and those
infected with other influenza viruses.
Methods
Setting
We have conducted active, population-based surveillance for
community-acquired pneumonia in all twenty hospitals in two
Thailand provinces since 2002–2003 [8]. Sa Kaeo province, on
the Cambodian border, had a 2009 population of 544,000, and
Nakhon Phanom province, which borders Laos in northeastern
Thailand, had a 2009 population of 747,000 [9]. In 2010, among
76 Thai provinces, Nakhon Phanom ranked 72nd with a per capita
GDP of $1290 while Sa Kaeo ranked 51st with a per capita GDP
of $2,303 [10].
Patients
A case of acute lower respiratory infection (ALRI) was defined
as evidence of both active infection (at least one of: reported fever,
reported chills, measured temperature .38.2 or ,35uC, or an
abnormal white blood cell count or differential) and lower
respiratory tract disease (at least one of: abnormal breath sounds,
documented tachypnea, cough, sputum production, or dyspnea) in
a hospitalized patient. Every other ALRI case-patient was
systematically sampled for possible participation in an etiology
study. Sampling was done by ward (e.g., male, female, pediatric)
and chronologically based on admission time. Chest radiographs,
if performed, were digitized and interpreted by a panel of
radiologists using standard criteria as previously described [11].
Ethics Statement
All adult participants and guardians of children aged ,18 years
provided written consent for study enrollment. A CDC Institu-
tional Review Board and the Ethical Review Committee of the
Thailand Ministry of Public Health approved this study.
Laboratory Testing
Nasopharyngeal swab specimens were collected from enrolled
patients using a polyester swab (PuritanH, Guilford, ME, USA). In
Nakhon Phanom, nasopharyngeal specimens were collected using
flocked swabs (FLOQSwabsTM, Copan, Murrieta, CA, USA)
starting in July 2010. Specimens were collected at the time of
enrollment and were stored at 4–8uC for ,24 hours before being
frozen at 270uC. Specimens were transported weekly on dry ice to
the Thailand National Institute of Health. All specimens were
tested for influenza A and B viruses by real-time reverse
transcription polymerase chain reaction (rRT-PCR) [12]. Speci-
mens that were positive for influenza A were tested for influenza A
subtypes using probes and primers developed by the U.S. CDC for
H1 (i.e., seasonal H1), H3, and influenza A(H1N1)pdm09 [12].
Nasopharyngeal specimens were also tested for respiratory
syncytial virus and adenovirus by PCR [7]. Participants aged
.17 years provided urine that was tested for the presence of
Streptococcus pneumoniae (pneumococcus) by antigen detection using
the Binax NOWH rapid immunochromatographic assay (Scarbor-
ough, ME). Blood cultures were performed as clinically indicated
[13].
Supplemental Data Collection
As part of the response to the 2009 influenza pandemic,
additional information on underlying conditions, influenza vacci-
nation status, and antiviral treatment was collected using a
standard questionnaire on a non-systematic sample of study
patients from October 2009 through August 2010.
Statistical Analysis
The study period included January 2009 through December
2010. Clinical and demographic characteristics were compared
among patients infected with influenza A virus subtypes and those
infected with influenza B virus. Dichotomous variables were
compared by chi-square or Fisher’s exact test and continuous
variables by t-test or Kruskal-Wallis. The crude age-specific
incidence of influenza-associated ALRI hospitalizations was
calculated for the 2-year study period by dividing the number of
rRT-PCR-confirmed influenza cases by the combined population
of the two provinces [9]. To account for missed cases due to the
sampling frame and non-enrollment of eligible patients, we
calculated the adjusted incidence by assuming that the proportion
positive for influenza viruses was the same among hospitalized,
enrolled ALRI patients as hospitalized ALRI patients who did not
enroll. The proportion of enrolled patients that were influenza
virus positive was multiplied by the total number of eligible (i.e.,
hospitalized with ALRI) patients to serve as the numerator for
adjusted incidence calculations. Patients hospitalized with ALRI
.1 times within 14 days were counted as a single case. Confidence
intervals (CI) around the adjusted influenza incidence were
calculated using the 95% CI for the proportion of influenza
positive cases assuming a binomial distribution.
Results
During the study period, 28,076 patients were hospitalized with
ALRI (Figure 1). Of those, approximately 14,000 were sampled for
potential enrollment, and 7,207 consented to enroll and were
tested for influenza viruses; reasons for non-enrollment included
admission during evenings or weekends when study nurses were
not available (69%), patient or guardian refusal (29%), and
guardian unavailable to consent (2.3%). Among ALRI patients
who enrolled and were tested for influenza viruses, 3.1% (225)
required mechanical ventilation and 1.5% (110) died compared to
6.9% (1432) and 3.9% (807) of those who did not enroll (p,0.01
for both). These differences persisted across age groups; the
difference in case fatality proportion for enrolled vs. non-enrolled
was greater for patients aged $5 years (2.2% vs. 5.8%) than those
,5 years (0.25% vs. 0.38%).
Of the 7,207 enrolled patients, 902 (12.5%) tested positive for
an influenza virus, including 190 (7.8%) of 2,436 children aged ,5
years. Compared to influenza-negative patients, influenza-positive
patients were less likely to be age ,5 years (21% vs. 36%) and less
likely to be $65 years (14% vs. 23%) (p,0.01). After adjusting for
age, influenza-positive patients were more likely than influenza-
negative patients to have documented fever .38.0uC (56% vs.
37%, p,0.01), but less likely to die (0.44% vs. 1.7%, p = 0.01),
require intubation (1.2% vs. 3.4%, p,0.01), need oxygen therapy
(21% vs. 34%, p,0.01), or to have chest radiographs consistent
with pneumonia (37% vs. 58%, p,0.01). Nasopharyngeal
Influenza Hospitalization Rates in Thailand
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specimens were collected from influenza-positive patients a mean
of 0.86 days after admission compared to 1.04 days for influenza-
negative patients (p,0.01).
Among 902 influenza cases, 779 (86%) were influenza A, 120
(13%) were influenza B, and three were positive for both influenza
A (one each of influenza A(H1N1)pdm09, H1N1, and H3N2) and
B. Among influenza A cases, 417 (54%) were influenza
A(H1N1)pdm09, 270 (35%) were H3N2, one was A(H1N1)pdm09
and H3N2, 59 (7.6%) were H1N1, and 32 (4.1%) were not
subtyped.
Patients infected with influenza A(H1N1)pdm09 virus were
similar in age to those with H1N1 and influenza B but younger
than those with H3N2 (Table 1). The presence of fever, duration
of hospitalization, and the proportion of patients requiring
mechanical ventilation and oxygen therapy were similar across
influenza types and subtypes. Only four (0.4%) influenza-infected
ALRI patients died: one 55 year-old HIV-infected male infected
with influenza A(H1N1)pdm09 and three patients with H3N2 (33
year-old female, 75 year-old male, and 75 year-old female). None
of the patients who died were reported to have underlying cardiac,
renal, liver, or cerebrovascular disease; the 33 year-old female was
not pregnant but had history of malignancy. Of 490 (54%)
influenza-infected patients with chest radiographs performed, 411
(84%) had a final reading by the radiologist panel, of which 151
(37%) were interpreted as consistent with pneumonia.
Co-infection with RSV occurred in 30 (7.2%) patients with
influenza A(H1N1)pdm09, 29 (11%) with H3N2, and 8 (6.7%)
with influenza B virus (7.6% of all influenza-infected patients
were RSV-positive vs. 9.3% of influenza-negative patients). Of
68 influenza-RSV co-infections, 56% occurred among children
aged ,5 years with little variation by influenza subtype. No
patients co-infected with influenza and RSV died or required
mechanical ventilation, and mean hospital stay did not differ
significantly between influenza-RSV-co-infected and influenza-
only-infected patients (3.9 vs. 3.6 days, p = 0.35). Among 445
influenza-infected patients aged .17 years tested for pneumo-
coccus by urine antigen assay, 12 (2.7%) were positive
compared to 140 (4.4%) of influenza-negative patients. One
(25%) of four fatalities in influenza-infected patients was co-
infected with pneumococcus compared to 11 (2.5%) of 440 non-
fatalities (Fisher’s exact p = 0.10). Patients co-infected with
pneumococcus were more likely to require oxygen therapy
than those who tested negative for pneumococcus (58% vs.
28%, p = 0.04) but were not more likely to need mechanical
ventilation; co-infected patients had longer hospital stays (mean
5.0 vs. 3.8 days, p = 0.23), though not significantly so. Three
(0.34%) influenza-infected patients tested positive for adenovirus
compared to 145 (2.3%) influenza-negative patients. Blood
cultures were performed in 282 (31%) of influenza-infected
patients, and only one was positive for a potential pathogen
(Staphylococcus aureus in a 49 year-old female with influenza
A(H1N1)pdm09). In comparison, 2336 influenza-negative pa-
tients had blood cultured; 146 had a positive blood culture,
including seven positive for S. aureus and 12 positive for S.
pneumoniae. Among those with a blood culture, 25% had
received antibiotic treatment before culture collection, which is
consistent with previous descriptions from these sites [14]. Seven
(0.8%) influenza-infected patients were HIV-positive (two with
influenza A(H1N1)pdm09 virus, three with other influenza A
subtypes (H1N1, H3N2, and untyped), and two with influenza
B.
Figure 1. Influenza cases among patients hospitalized with acute lower respiratory infection (ALRI). Detailed legend. Influenza cases
among patients hospitalized with acute lower respiratory infection (ALRI) – Sa Kaeo and Nakhon Phanom, Thailand, January 2009 – December 2010.
*NT, not typed **Nurses did not routinely enroll patients at night or on weekends.
doi:10.1371/journal.pone.0048609.g001
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Seasonality
Influenza peaks occurred twice in each study year, with smaller
peaks occurring in January – March and larger peaks occurring
during July – September (Figure 2). Seasonal influenza A(H1N1)
virus predominated in the first peak of 2009 and was infrequent
thereafter. Influenza A(H1N1)pdm09 virus predominated in the
early part of the second peak in 2009 followed by an increase in
H3N2 cases. Influenza infections in 2010 were a mix of influenza
A(H1N1)pdm09, H3N2 and influenza B viruses.
Influenza-associated ALRI Hospitalization Incidence
The crude incidence rate of influenza-associated ALRI hospi-
talizations during 2009–2010 was 35 per 100,000 person-years;
after adjusting for sampling and enrollment, the overall rate was
136 per 100,000 person-years (95% CI = 127–144 per 100,000).
Adjusted rates were highest in children aged ,5 years at 477 per
100,000 person-years (95% CI = 414–547 per 100,000) and adults
aged $75 years at 407 per 100,000 person-years (95% CI = 312–
519 per 100,000) (Figure 3). Rates among children aged ,1 year
did not differ from rates among those ,5 years overall. The
adjusted incidence rate of hospitalized influenza A(H1N1)pdm09
ALRI cases alone was 63 per 100,000 person-years overall (95%
CI = 57–69 per 100,000) (46% of total incidence), 216 per 100,000
among children aged ,5 years (95% CI = 173–266 per 10,000)
(45% of total), and 83 per 100,000 among adults $75 years (95%
CI = 43–144 per 10,000) (20% of total). The adjusted influenza-
associated hospitalization rate overall in 2010 (143 [95%
CI = 131–154] per 100,000 person-years) was slightly higher than
that in 2009 (128 [95% CI = 116–141] per 100,000 person-years).
To account for the fact that non-enrolled ALRI patients were
more likely to have severe disease (mechanical ventilation or death)
than enrolled patients and that a lower proportion of severely ill
patients tested positive for influenza viruses, we re-calculated the
adjusted incidence using influenza-positive percentages specific to
severe vs. non-severe disease. The adjusted incidence accounting
for severity was 135 per 100,000 person-years, almost identical to
the incidence not accounting for severity (136 per 100,000 person-
years).
Supplemental Data Collection
From October 2009 through August 2010, supplemental data
were collected for 475 (14%) study patients, including 31% (82/
261) of patients who tested positive for an influenza virus
compared to 13% (393/3126) of those who tested negative
(p,0.01). Among these 475 patients, 443 (93%) received antiviral
treatment (all oseltamivir); 50% received treatment within 2 days
of symptom onset and 97% within 2 days of admission. Influenza-
negative patients were as likely to receive therapy as those who
were influenza-positive (92% vs. 98%, p = 0.09). Influenza
vaccination was documented for 32 (7.2%) patients, but only
Table 1. Characteristics of patients hospitalized with influenza-associated acute lower respiratory infection – Sa Kaeo and Nakhon
Phanom, Thailand, January 2009 – December 2010. Values represent n (%) unless otherwise stated.
A(H1N1)pdm09
(N = 417) A(H1N1) (N = 59) A(H3N2) (N = 270)
A, unsubtyped
(N = 32) B (N = 120) p-value
Age, years, median (range) 16 (0–92) 14 (0–82) 45 (0–95) 15.5 (0–80) 15 (0–86) ,0.01a
Age group, years
Age ,5 86 (20.6)* 8 (13.6) 60 (22.2) 5 (15.6) 31 (25.8) ,0.01¥
5–17 136 (32.6) 24 (40.7) 30 (11.1) 14 (43.8) 39 (32.5)
18–49 117 (28.1) 11 (18.6) 56 (20.7) 4 (12.5) 25 (20.8)
50–64 45 (10.8) 8 (13.6) 59 (21.8) 5 (15.6) 7 (5.8)
$65 33 (7.9) 8 (13.6) 65 (24.1) 4 (12.5) 18 (15.0)
Temperature .38uC 243 (58.4) 36 (61.0) 153 (56.7) 16 (50.0) 57 (47.5) 0.17¥
Fever by report 409 (98.1) 55 (93.2) 266 (98.5) 31 (96.9) 118 (98.3) 0.07¥
Days in hospital, median 3 3 3 3 3 0.71a
Death 1 (0.2) 0 3 (1.1) 0 0 0.29¥
Intubation 7 (1.7) 1 (1.7) 2 (0.8%) 0 1 (1.3) 0.70¥
Oxygen therapy 79 (19.0) 14 (23.7) 71 (26.4) 5 (15.6) 20 (16.7) 0.07¥
Co-infections
RSV 30 (7.2)b 0 29 (10.9) 1 (3.1) 8 (6.7) 0.03¥
Adenovirus 2 (0.48)b 1 (1.7) 0 0 0 0.20¥
Streptococcus pneumoniae (urine antigen
testing among age $18 years)*
4 (2.1) of 188d 0 of 27 8 (4.7) of 170d 0 of 13 1 (2.1)of 47 0.38¥
Blood culture positive of those with culture 1 of 121c 0 of 23 0 of 92 0 of 9 0 of 35
CXR with pneumonia (of those with CXR
read)
68 (33.7) of 202 9 (31.0) of 29 48 (32.2) of 149 5 (33.3) of 15 20 (35.1) 57 0.97¥
¥Pearson chi-square test for homogeneity, excluding influenza A cases without subtype.
aKruskal-Wallis test, excluding influenza A cases without subtype.
*Among those tested for Streptococcus pneumoniae by the BinaxH urine antigen assay.
bOne A(H1N1)pdm09-infected patient was also positive for adenovirus and RSV.
cOne patient with Staphylococcus aureus.
dOne patient positive for both influenza A(H1N1)pdm09 and A(H3N2) tested positive for Streptococcus pneumoniae.
CXR, chest x-ray.
doi:10.1371/journal.pone.0048609.t001
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one patient was vaccinated after the monovalent influenza
A(H1N1)pdm09 vaccine was available. Co-morbid conditions
were identified among 23% of influenza-positive versus 38% of
influenza-negative patients (p = 0.01); asthma was most common
(16% of influenza-positive).
Discussion
We documented the substantial incidence and the seasonality of
influenza in rural Thailand for a 2-year period that included the
2009 pandemic using ongoing active, population-based surveil-
lance for hospitalized cases of influenza-associated ALRI. Influ-
enza incidence was largely attributable to influenza
A(H1N1)pdm09 virus but with important contributions from
Figure 2. Hospitalized cases of influenza-associated acute lower respiratory infection by month of admission. Detailed legend.
Hospitalized cases of influenza-associated acute lower respiratory infection by month of admission – Sa Kaeo and Nakhon Phanom, Thailand, January
2009 – December 2010. Cases with more than one influenza type or subtype are included in each category: three cases positive for influenza B and A
(H1N1pdm09, H3N2, H1N1), one case positive for influenza A (H1N1)pdm09 and A (H3N2).
doi:10.1371/journal.pone.0048609.g002
Figure 3. Incidence rate of influenza-associated acute lower respiratory infection hospitalizations. Detailed legend. Incidence rate of
influenza-associated acute lower respiratory infection hospitalizations, by type/subtype, Sa Kaeo and Nakhon Phanom provinces, Thailand, January
2009–December 2010. Bars show 95% confidence intervals Rates are adjusted for sampling and non-participation.
doi:10.1371/journal.pone.0048609.g003
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influenza A(H3N2), and from influenza B. Our results add to the
limited but growing literature on the high burden of influenza in
tropical settings [1,3,15] and highlight the importance of
prevention and control measures, which are underutilized in this
region where influenza historically has not been considered an
important cause of serious illness.
The incidence of hospitalized influenza cases overall was highest
in children aged ,5 years and adults 75 years and older (.400 per
100,000 person-years in both groups), which is typical of rates
documented previously in Thailand [3] and in temperate regions
[16]. The incidence in children ,5 years (477 per 100,000 person-
years) was higher than that in a previous report (120–330 per
100,000) [3], which likely relates to the impact of the pandemic,
annual variation in influenza subtypes and associated burden, and
a change in enrollment criteria to improve capture of influenza-
associated ALRI (eliminated requirement for chest radiograph).
The age distribution of influenza A(H1N1)pdm09 cases differed
from that of seasonal influenza; the relatively lower incidence in
older age groups was consistent with the epidemiology of influenza
A(H1N1)pdm09 elsewhere in the world [17] and supports the
presence of existing immunity in older populations, as has been
documented in the U.S. [18]. Immunity in older age groups was
likely due to cross-protective antibodies from infection with related
influenza strains to which younger populations had not been
exposed [18,19]. Cross-protective immunity from prior vaccina-
tion with related influenza strains is a very unlikely explanation,
given the historically low rates of vaccination in Thailand.
Although Thailand began providing influenza vaccination to
elderly persons in 2009, our data suggest that coverage is low.
Few data on influenza incidence during the pandemic are
available from tropical regions. A preliminary report from
Guatemala found influenza A(H1N1)pdm09 hospitalization rates
of 7.1–8.8 per 100,000 persons during 8 months when circulation
was peaking [2]. In the U.S., the CDC’s Emerging Infections
Program (EIP) found an influenza hospitalization rate among
children aged ,5 years during the pandemic (April 2009– May 1,
2010) of 83 per 100,000 [17]; rates in older age groups ranged
from 32 to 34 per 100,000. The age-specific rates were
substantially lower than our rates for Thailand; for the youngest
age groups, rates in Thailand were higher even when limited only
to influenza A(H1N1)pdm09, which caused .99% of cases in the
U.S. [17]. This comparison is limited by the fact that influenza
testing in EIP surveillance was clinician driven, which results in
low sensitivity (39% in children aged ,5 years [20]) to capture
hospitalized influenza cases. However, the sensitivity was likely
higher during the pandemic due to more frequent influenza testing
and increased use of more sensitive diagnostic tests (i.e., PCR).
Even if the U.S. rates in children ,5 were adjusted to account for
39% sensitivity (i.e., divided by 0.39), Thailand rates were still
higher. A separate analysis of U.S. EIP data corrected for
underreporting estimated an adjusted influenza A(H1N1)pdm09
hospitalization rate of 90.2 per 100,000 persons overall (range
64.2–132.4), with the highest rates in ages 0–17 years (117.4 per
100,000, range 83.5–172.4) [21], which are closer to but still lower
than Thailand rates.
The co-circulation of seasonal and pandemic influenza viruses
during the 2-year period allowed us to compare characteristics of
patients infected with different subtypes during the same season.
Patients infected with H3N2 virus were significantly older than
those infected with influenza A(H1N1)pdm09, H1N1, or influenza
B, although the proportion of cases aged ,5 years was not
significantly different. We found no difference in clinical severity in
patients infected with influenza A(H1N1)pdm09 and other
influenza viruses. A comparison of patients with pandemic and
other influenza viruses in Guatemala found similar characteristics,
although patients in the Guatemala study had more severe disease
overall [22].
Our findings likely underestimate the rate of severe influenza
cases and deaths by 2–3 times, due to challenges enrolling patients
with severe illness. ALRI surveillance in these provinces identified
32 deaths among 9,778 children during 2009–10, but only six
were enrolled in our study and tested for influenza viruses. An
early report of the first 272 hospitalized influenza A(H1N1)pdm09
cases in the U.S. found that 25% required intensive care, 15%
needed mechanical ventilation, and 7% died [23]. This compares
to only one (0.4%) influenza A(H1N1)pdm09-associated ALRI
death in our report (4 (0.4%) influenza deaths overall). The U.S.
report may have been biased toward higher severity, because
reporting was passive and influenza A(H1N1)pdm09 testing was
clinician driven, which favors capturing severe cases. A report
from Guatemala among 76 hospitalized influenza A(H1N1)pdm09
cases found that 11% required mechanical ventilation and 15%
died [22]. In Malaysia, 3.7% of 1,362 hospitalized patients aged
,12 years with influenza A(H1N1)pdm09 died [24]. A case series
from another Thailand province described five (21%) deaths
among 24 hospitalized adults with influenza A(H1N1)pdm09-
associated pneumonia [25]. In contrast, investigators in China
actively screened arriving passengers at airports and found no
deaths among 426 influenza A(H1N1)pdm09-infected patients,
351 of whom had received oseltamivir [26].
The low case fatality proportion in our sites should be
considered in light of the availability and use of oseltamivir in
Thailand, where national guidelines during the pandemic
recommended treatment of influenza-infected patients with
complicated illness (e.g., pneumonia, altered level of conscious-
ness), failure to improve within 48 hours, and high-risk conditions
(e.g., pregnancy, chronic illnesses). Data on a subset of our patients
showed that .90% of those hospitalized with ALRI received
oseltamivir, 50% within two days of symptom onset. Oseltamivir
access was likely improved by domestic production of a generic
formulation and by prepositioning the drug at government
hospitals. Further, hospital access in Thailand is very good,
allowing patients to be treated before illness progression. Our
lower case fatality proportion may also have been related to the
low prevalence of co-morbid conditions (23%) compared to other
studies [23,27]. The relatively low proportion of patients with co-
morbid conditions also suggests that clinicians may have had a
lower threshold for hospitalization.
Similar to trends seen in the U.S. and other parts of the world,
Thailand had a rapid disappearance of the H1N1 virus and
relatively lower infection rates from influenza A(H1N1)pdm09
virus in older adults compared to previous influenza seasons.
However, in contrast to the U.S. and most temperate regions
where influenza A(H1N1)pdm09 accounted for .99% of influen-
za infections [28], Thailand saw continued circulation of H3N2
and influenza B after the introduction of influenza
A(H1N1)pdm09. Influenza peaked in January – March and July
– September of 2009 and 2010, consistent with patterns observed
in most pre-pandemic years [3,8]. Surveillance data from 2011
have shown a predominance of influenza A (H3N2) and B in both
inpatient and outpatient settings.
Few studies have systematically assessed the prevalence of other
pathogens among influenza-infected patients by means other than
blood culture [22,29]. Co-infections with RSV occurred in 7%
with the majority among patients aged ,5 years and with similar
frequency by influenza subtype. We found no differences in
clinical severity between influenza-infected patients with and
without RSV co-infection. Although numbers were small, our
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findings suggested that co-infection with pneumococcus increased
disease severity, as evidenced by a higher percentage of patients
dying and requiring oxygen therapy. Compared to our findings, a
report from Guatemala found higher prevalences of co-infection
with RSV (12%) and pneumococcus (22%) among hospitalized
influenza pneumonia patients [22].
Strengths of our analysis include systematic sampling from
active surveillance for ALRI, lack of reliance on clinical reporting
or testing, and a known catchment area. However, the findings
must be interpreted in light of several limitations. We lacked data
on some of the known or potential risk factors for severe influenza
infection, including pregnancy and obesity. Our incidence
estimates relied on statistical adjustments that assumed enrolled
and non-enrolled patients had identical prevalences of influenza
positivity. Patients admitted on nights and weekends were under-
represented in our sample and may have differed from patients
admitted on weekdays in terms of demographics, disease severity,
and influenza prevalence. Finally, data on co-infections with
bacteria other than pneumococcus relied on blood culture as the
single diagnostic modality, and ,30% of patients had cultures,
25% of whom were pre-treated with antibiotics.
Using active, population-based surveillance, we found a high
incidence of hospitalized influenza ALRI infections in Thailand,
exceeding estimates from most other nations and confirming
influenza’s substantial contribution to severe respiratory illness,
including pneumonia, in Thailand and likely in Southeast Asia.
The high disease burden in young children is particularly
noteworthy and underscores the role that influenza vaccination
should play in strategies to prevent childhood pneumonia globally
[30]. During the 2009 pandemic, the Thailand Ministry of Public
Health expanded influenza vaccine recommendations to include
children age 6 months to 2 years. Efforts to maintain and
implement this recommendation are warranted. These data will
contribute to ongoing efforts to estimate the global burden of the
2009 influenza pandemic in young children.
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